Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2025-12-26 @ 10:20 PM
Study NCT ID:
NCT02480712
Status:
COMPLETED
Last Update Posted:
2018-11-16
First Post:
2015-06-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-22
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-22
First Submit QC Date:
None
Study First Post Date:
2015-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-26
Results First Submit QC Date:
None
Results First Post Date:
2017-06-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2018-11-16
Last Update Post Date Type:
ACTUAL